Benefit of Early Palliative Care Intervention in End-Stage Liver Disease Patients Awaiting Liver Transplantation.

Patients with end-stage liver disease have a predictable and progressive decline in their quality of life because of physical symptoms and psychological distress. Early palliative care intervention (EPCI) correlates with better symptom control and mood. We aimed to improve symptomatology and mood in liver transplant candidates by implementing a longitudinal multidisciplinary EPCI.
Depression level and symptom burden were assessed with Center for Epidemiological Studies Depression Scale and a modified liver-specific Edmonton Symptom Assessment System scale.
All patients referred for liver transplant evaluation between July 2013 and May 2014 were scheduled for EPCI.
After EPCI, 50% of moderate-to-severe symptoms improved (P < 0.05), and 43% of patients showed improvement in clinically significant depressive symptoms (P = 0.003). Notably, patients with more symptoms showed a greater improvement in Center for Epidemiological Studies Depression Scale scores (P = 0.001).
Implementation of EPCI improved symptom burden and mood in end-stage liver disease patients awaiting transplant.
AuthorsAlexandra J Baumann, David S Wheeler, Marva James, Roberta Turner, Arthur Siegel, Victor J Navarro
JournalJournal of pain and symptom management (J Pain Symptom Manage) Vol. 50 Issue 6 Pg. 882-886.e2 (Dec 2015) ISSN: 1873-6513 [Electronic] United States
PMID26303186 (Publication Type: Journal Article)
CopyrightCopyright © 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: